Center for Aquaculture Technologies
- Company typePrivate
- Founded2012
- HeadquartersSan Diego, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
Center for Aquaculture Technologies firmographics
Firmographics- Name
- Center for Aquaculture Technologies
- Website
- https://aquatechcenter.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Center for Aquaculture Technologies industry classification
Industry- Product category
- Aquaculture Biotechnology
- NAICS
- Animal Production and Aquaculture (112), Aquaculture (11251)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Cloning & Advanced Reproductive Technologies Services (AFAEAJAL)
- akta.pro secondary industries
- Genomic Testing & Genetic Evaluation Services (AFAEAJAC), Aquaculture Breeding & Genetics Services (e.g., broodstock improvement) (AFAEAJAN), Aquaculture Health, Biosecurity & Veterinary Services (AFAEAAAK)
Keywords
Where Center for Aquaculture Technologies is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Markets served
Center for Aquaculture Technologies business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Center for Aquaculture Technologies product offering
Product offeringCore offering
Center for Aquaculture Technologies (CAT) is an aquaculture-focused research and development company that applies modern genetic improvement technologies to the aquaculture sector. The company specializes in genome editing solutions for sterility induction in finfish and Morpholino-based gene silencing for genetic improvement research. CAT partners with industry clients and academic institutions to develop, validate, and license genetic technologies that support sustainable aquaculture production.
Product overview
Center for Aquaculture Technologies (CAT) offers genetic technologies for aquaculture, including genome editing solutions for sterility and Morpholinos-based gene silencing technologies for inducing sterility in finfish species. The company operates through research partnerships with universities and other organizations for product development and testing.
Differentiator
Problem solved
Functional benefit
Products and services
- Genome Editing for Sterility in Finfish A specialized R&D service applying proprietary genome editing technologies to induce sterility in finfish species, supporting breeding program containment, regulatory compliance, and genetic control in commercial aquaculture operations.
- Morpholino-based Gene Silencing Technology Proprietary Morpholino-based gene silencing offering used for functional genomics research and genetic improvement in aquaculture species, made available through licensing arrangements and collaborative research partnerships.
- Genetic Improvement Research Services Broader contract R&D services that apply CAT's genetic improvement technologies, including genome editing and Morpholino-based tools, to aquaculture challenges for industry clients, breeding programs, and academic collaborators.
Quantifiable outcome
- Targeting 100% sterility rates in Atlantic salmon
Companies that use Center for Aquaculture Technologies
Customer profileSegments1 record
Ideal customer profiles1 record
Center for Aquaculture Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Center for Aquaculture Technologies partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- University of Maryland, Baltimore County (UMBC)coreExclusive licensing agreement covering two patents for inducing sterility in finfish using Morpholinos technology that silences genes critical for germ cell development. The partnership includes a sponsored research agreement aimed at achieving 100% sterility rates in Atlantic salmon with potential applications across all finfish species.
- LanzaTechcorePartnership for testing and prototyping fish feed applications using LanzaTech Nutritional Protein (LNP), a bacterial protein product derived from CO2 and hydrogen. CAT is collaborating on development of sustainable aquaculture feed ingredients.
Recent moves4 records
Expansion highlights4 records
Center for Aquaculture Technologies competitors and assessment
Company assessmentOthers
- Veramaris: Veramaris produces sustainable algal oil for aquaculture feed, addressing the same sustainability-driven feed reformulation theme as CAT's LanzaTech partnership. It is adjacent/thematic rather than directly competitive.
- Cargill Aqua Nutrition: Cargill's aqua nutrition business supplies feed and feed-related services to aquaculture producers globally, including salmon. It is an adjacent ecosystem participant — overlapping customer base but not competing in genetics/sterility R&D.
Direct peers
- AquaBounty Technologies: AquaBounty develops genetically modified Atlantic salmon with a focus on sterility and growth traits. It is the most direct peer to CAT because both are aquaculture-biotech companies commercializing genetic technologies (sterility/transgenic traits) targeting the salmon industry.
- Benchmark Genetics: Benchmark's breeding and genetics division provides selective breeding programs and genetic services for salmon and other aquaculture species. It is a direct competitor in aquaculture genetic improvement, the same category CAT addresses via sterility and genome editing.
- Salmobreed: Salmobreed is a salmon breeding company focused on genetic improvement of Atlantic salmon for the aquaculture industry. It is a direct peer in salmon genetics and a relevant comparable for CAT's salmon-focused sterility work.
- Xelect: Xelect offers genetic selection, genotyping, and breeding program services to the aquaculture industry, particularly salmon and other finfish. It is a direct peer as a service-oriented aquaculture genetics R&D provider competing for similar customers.
Broad incumbents
- Akva Group: Akva Group supplies equipment and technology to the global aquaculture industry, including salmon farming infrastructure. It is a broad incumbent whose customer base overlaps with CAT's potential customers in commercial salmon production.
- Innovasea: Innovasea provides aquaculture technology solutions spanning fish farming hardware, monitoring, and genetic services. It is a broad incumbent in aquaculture tech with partial overlap to CAT through genetic and breeding services.
- Hendrix Genetics: Hendrix Genetics is a major multi-species animal breeding company with an aquaculture division covering salmon, shrimp, and trout. It is a broad incumbent — overlapping in aquaculture genetics but operating across many species and geographies.
Emerging players
- STINE AQUA: STINE AQUA develops aquaculture genetic technologies, including sterility and genome-editing approaches for fish. It is an emerging peer with overlapping gene-silencing/sterility ambitions, making it a credible comparable despite being smaller and earlier-stage than CAT.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Center for Aquaculture Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Center for Aquaculture Technologies leadership team
Management profileNumber of profiles
Profiles4 records
Center for Aquaculture Technologies funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Center for Aquaculture Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Center for Aquaculture Technologies
What does Center for Aquaculture Technologies do?
Center for Aquaculture Technologies (CAT) is an aquaculture-focused research and development company that applies modern genetic improvement technologies to the aquaculture sector. The company specializes in genome editing solutions for sterility induction in finfish and Morpholino-based gene silencing for genetic improvement research. CAT partners with industry clients and academic institutions to develop, validate, and license genetic technologies that support sustainable aquaculture production.
Is Center for Aquaculture Technologies a public or private company?
Center for Aquaculture Technologies is a private company. It is classified as venture growth investor backed and is currently operating.
When was Center for Aquaculture Technologies founded?
Center for Aquaculture Technologies was founded in 2012. It employs 51 to 100 people.
Where is Center for Aquaculture Technologies based?
Center for Aquaculture Technologies is headquartered in San Diego, United States, in the North America region.
Who are Center for Aquaculture Technologies's main competitors?
Others on record are Veramaris and Cargill Aqua Nutrition. Direct peers are AquaBounty Technologies, Benchmark Genetics, Salmobreed and Xelect. Broad incumbents are Akva Group, Innovasea and Hendrix Genetics. STINE AQUA is listed as an emerging player.
Does Center for Aquaculture Technologies have an API?
No public API is recorded for Center for Aquaculture Technologies.
What industry is Center for Aquaculture Technologies in?
Center for Aquaculture Technologies's product category is Aquaculture Biotechnology. Its primary akta.pro industry code is AFAEAJAL, Cloning & Advanced Reproductive Technologies Services, with a secondary code of AFAEAJAC, Genomic Testing & Genetic Evaluation Services. Its NAICS code is 112 and its SIC code is 8731.